Page 18 - Research Models News Today

Inotiv (NASDAQ:NOTV – Get Free Report) and OmniAb (NASDAQ:OABI – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk. Risk and Volatility Inotiv has a beta of 2.43, […]

Mawer Investment Management Ltd. grew its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,833 shares of the medical research company’s stock after purchasing an additional 500 shares during […]

Lmcg Investments LLC raised its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,708 shares of the medical research company’s stock after purchasing an additional […]

The humanized mouse and rat model market boasts a total revenue value of $349 million by 2028.

American Capital Management Inc. grew its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 175,000 shares of the medical research company’s stock after […]

Wells Fargo & Company initiated coverage on shares of Inotiv (NASDAQ:NOTV – Free Report) in a research note published on Thursday morning, Marketbeat Ratings reports. The firm issued an overweight rating and a $9.00 price objective on the stock. Inotiv Price Performance Inotiv stock opened at $7.12 on Thursday. The company has a debt-to-equity ratio […]

State of Michigan Retirement System increased its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 0.7% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,930 shares of the medical research company’s stock after acquiring an additional 100 shares […]

Sumitomo Mitsui Trust Holdings Inc. lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 0.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 141,119 shares of the medical research company’s stock after selling 1,066 shares during the period. Sumitomo Mitsui […]

/PRNewswire/ -- In the near future, the humanized mouse and rat model industry is set to undergo transformative advancements, revolutionizing biomedical...

Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has earned an average rating of “Moderate Buy” from the nine analysts that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month […]